000			02413 a2200709 4500
005			20250516130201.0
264		0	_c20130812
008			201308s 0 0 eng d
022			_a1949-2553
024	7		_a10.18632/oncotarget.790 _2doi
040			_aNLM _beng _cNLM
100	1		_aChung, Suyoun
245	0	0	_aDevelopment of an orally-administrative MELK-targeting inhibitor that suppresses the growth of various types of human cancer. _h[electronic resource]
260			_bOncotarget _cDec 2012
300			_a1629-40 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdministration, Oral
650	0	4	_aAnimals
650	0	4	_aAntineoplastic Agents _xadministration & dosage
650	0	4	_aCell Proliferation _xdrug effects
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDrug Design
650	0	4	_aFemale
650	0	4	_aHigh-Throughput Screening Assays
650	0	4	_aHumans
650	0	4	_aInhibitory Concentration 50
650	0	4	_aInjections, Intravenous
650	0	4	_aMCF-7 Cells
650	0	4	_aMale
650	0	4	_aMice
650	0	4	_aMice, Inbred BALB C
650	0	4	_aMice, Inbred NOD
650	0	4	_aMice, SCID
650	0	4	_aMicrofilament Proteins _xmetabolism
650	0	4	_aMolecular Structure
650	0	4	_aMolecular Targeted Therapy
650	0	4	_aNIH 3T3 Cells
650	0	4	_aNaphthyridines _xadministration & dosage
650	0	4	_aNeoplasms _xdrug therapy
650	0	4	_aPhosphorylation
650	0	4	_aProteasome Endopeptidase Complex _xmetabolism
650	0	4	_aProtein Kinase Inhibitors _xadministration & dosage
650	0	4	_aProtein Serine-Threonine Kinases _xantagonists & inhibitors
650	0	4	_aRNA Interference
650	0	4	_aSmall Molecule Libraries
650	0	4	_aStructure-Activity Relationship
650	0	4	_aTime Factors
650	0	4	_aTransfection
650	0	4	_aTumor Burden _xdrug effects
650	0	4	_aXenograft Model Antitumor Assays
650	0	4	_asrc Homology Domains
700	1		_aSuzuki, Hanae
700	1		_aMiyamoto, Takashi
700	1		_aTakamatsu, Naofumi
700	1		_aTatsuguchi, Ayako
700	1		_aUeda, Koji
700	1		_aKijima, Kyoko
700	1		_aNakamura, Yusuke
700	1		_aMatsuo, Yo
773	0		_tOncotarget _gvol. 3 _gno. 12 _gp. 1629-40
856	4	0	_uhttps://doi.org/10.18632/oncotarget.790 _zAvailable from publisher's website
999			_c22387296 _d22387296